HIV Update: Impact on Chronic Diseases

Activity Preview

Widespread use of combination antiretroviral therapy in the last 2 decades has given rise to an aging HIV population. Management has shifted from acute opportunistic infection treatment to chronic comorbid disease state management. Common HIV comorbid conditions include hyperlipidemia, diabetes, cardiovascular disease, kidney dysfunction, psychiatric illness, and viral hepatitis B and C coinfection. While treatment guidelines do not drastically differ in recommendations, there are unique aspects of care to consider for persons living with HIV infection.

Learning Objectives: 

At the completion of this activity, the participant will be able to:

1. Discuss common co-morbid conditions in HIV-infected patients: cardiovascular disease, dyslipidemia, diabetes, hypertension, kidney disease, psychiatric illnesses, and viral hepatitis B and C co-infection.
2. Explain the role of new HIV pharmacotherapy in patients with comorbid conditions.
3. For an HIV patient with multiple co-morbidities, identify potential drug interactions and propose solutions.
4. Monitor treatment response and adverse events in patients with HIV and co-morbid conditions.
5. Identify key differences in the management of chronic disease states in patients living with HIV infection versus HIV-negative patients.

Activity type: Knowledge-based

Target Audience: Pharmacists 

Learning level: 1

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-17-225-H02-P.

To obtain credit for "HIV Update: Impact on Chronic Diseases" complete the assessment with a grade of 70% or better, evaluation questions, and CLAIM credit. Participants will need to have a valid pharmacist.com username and password to claim credit. After your credit has been claimed, please visit CPE monitor for your transcript.

APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and you will not be permitted to submit the assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: August 1, 2017
Expiration date: August 1, 2020 - NO CREDIT GRANTED AFTER THIS DATE

Development

"HIV Update: Impact on Chronic Diseases” is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.

Authors

Jessica Conklin, PharmD, PhC, BCACP, CDE, AAHIVP

University of New Mexico Health Sciences Center College of Pharmacy

629 Monroe St SE

Albuquerque, NM 87108-3505

JeConklin@salud.umn.edu

Larry J. Pineda, PharmD, PhC, BCPS, AAHIVP

University of New Mexico College of Pharmacy

1 University of New Mexico, MSC 09 5360

Albuquerque, NM 87131-0001

ljpineda@salud.unm.edu

Advisory Board

Betty Dong, BSPharm PharmD, AAHIVP, FAPHA, FACCP, FASHP

Professor of Clinical Pharmacy and Family and Community Medicine

Clinical Pharmacy and Family and Community Medicine

University of California San Francisco Schools of Pharmacy and Medicine

San Francisco, CA

Dong.Betty@ucsf.edu

Disclosures

Jessica Conklin, PharmD, PhC, BCACP, CDE, AAHIVP declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.

Larry J. Pineda, PharmD, PhC, BCPS, AAHIVP declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.

Betty Dong, BSPharm PharmD, AAHIVP, FAPHA, FACCP, FASHP declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.

APhA's editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete APhA staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.

Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and Internet access is required to complete this activity.  Please visit our website to view the Technology System Requirements to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-17-225-H02-P 0.2 CEUs August 01, 2017 - August 01, 2020